Published in Protein Sci on December 01, 1999
Metal site occupancy and allosteric switching in bacterial metal sensor proteins. Arch Biochem Biophys (2011) 1.01
Structural features specific to plant metallothioneins. J Biol Inorg Chem (2011) 0.98
Accumulation of cadmium in insulin-producing β cells. Islets (2012) 0.85
Oxidative dimerization in metallothionein is a result of intermolecular disulphide bonds between cysteines in the alpha-domain. Biochem J (2001) 0.82
Metal ion binding properties of Triticum [corrected] aestivum Ec-1 metallothionein: evidence supporting two separate metal thiolate clusters. J Biol Inorg Chem (2007) 0.81
Clinical significance of metallothioneins in cell therapy and nanomedicine. Int J Nanomedicine (2013) 0.79
Role of zinc metallothionein-3 (ZnMt3) in epidermal growth factor (EGF)-induced c-Abl protein activation and actin polymerization in cultured astrocytes. J Biol Chem (2011) 0.78
Structural characterization and thermal stability of Notothenia coriiceps metallothionein. Biochem J (2001) 0.78
Directly decoupled diffusion-ordered NMR spectroscopy for the analysis of compound mixtures. Chemistry (2014) 0.78
New proteins found interacting with brain metallothionein-3 are linked to secretion. Int J Alzheimers Dis (2010) 0.77
Phylogenetic divergence of fish and mammalian metallothionein: relationships with structural diversification and organismal temperature. J Mol Evol (2003) 0.77
The effect of nitric oxide on metal release from metallothionein-3: gradual unfolding of the protein. J Biol Inorg Chem (2007) 0.77
Use of (113)Cd NMR to probe the native metal binding sites in metalloproteins: an overview. Met Ions Life Sci (2013) 0.77
Influence of NH-Sgamma bonding interactions on the structure and dynamics of metallothioneins. J Mol Model (2009) 0.75
Protein folding and association: insights from the interfacial and thermodynamic properties of hydrocarbons. Proteins (1991) 36.69
Gradient-tailored excitation for single-quantum NMR spectroscopy of aqueous solutions. J Biomol NMR (1992) 17.71
1H, 13C and 15N chemical shift referencing in biomolecular NMR. J Biomol NMR (1995) 15.76
Determination of three-dimensional structures of proteins from interproton distance data by hybrid distance geometry-dynamical simulated annealing calculations. FEBS Lett (1988) 3.49
Biochemistry of metallothionein. Biochemistry (1988) 2.93
Chemistry and biochemistry of metallothionein. Experientia Suppl (1987) 2.29
Solution conformation of proteinase inhibitor IIA from bull seminal plasma by 1H nuclear magnetic resonance and distance geometry. J Mol Biol (1985) 2.29
Refined crystal structure of Cd, Zn metallothionein at 2.0 A resolution. J Mol Biol (1991) 1.70
Three-dimensional structure of proteins determined by molecular dynamics with interproton distance restraints: application to crambin. Proc Natl Acad Sci U S A (1986) 1.52
Three-dimensional structure of rabbit liver [Cd7]metallothionein-2a in aqueous solution determined by nuclear magnetic resonance. J Mol Biol (1988) 1.45
Conformation of [Cd7]-metallothionein-2 from rat liver in aqueous solution determined by nuclear magnetic resonance spectroscopy. J Mol Biol (1988) 1.24
Three-dimensional structure of potato carboxypeptidase inhibitor in solution. A study using nuclear magnetic resonance, distance geometry, and restrained molecular dynamics. Biochemistry (1987) 1.21
Interprotein metal exchange reactions of metallothionein. Experientia Suppl (1987) 0.98
Three-dimensional solution structure of Callinectes sapidus metallothionein-1 determined by homonuclear and heteronuclear magnetic resonance spectroscopy. Biochemistry (1995) 0.95
Enhanced neurotrophic activity in Alzheimer's disease cortex is not associated with down-regulation of metallothionein-III (GIF). Brain Res (1994) 0.93
Three-dimensional structure of human [113Cd7]metallothionein-2 in solution determined by nuclear magnetic resonance spectroscopy. J Mol Biol (1990) 0.91
Comparison of the solution conformations of human [Zn7]-metallothionein-2 and [Cd7]-metallothionein-2 using nuclear magnetic resonance spectroscopy. J Mol Biol (1992) 0.89
111Cd NMR studies of the domain specificity of Ag+ and Cu+ binding to metallothionein. Biochemistry (1996) 0.83
Amide proton exchange in human metallothionein-2 measured by nuclear magnetic resonance spectroscopy. J Mol Biol (1990) 0.78
Use of human immunodeficiency virus-1 protease inhibitors is associated with atherogenic lipoprotein changes and endothelial dysfunction. Circulation (2001) 3.25
Structure of the metal clusters in rabbit liver metallothionein. Proc Natl Acad Sci U S A (1980) 2.40
Association of cholesteryl ester transfer protein-TaqIB polymorphism with variations in lipoprotein subclasses and coronary heart disease risk: the Framingham study. Arterioscler Thromb Vasc Biol (2000) 2.10
MRI inter-slice reconstruction using super-resolution. Magn Reson Imaging (2002) 2.06
31P NMR studies of the solution structure and dynamics of nucleosomes and DNA. Nucleic Acids Res (1979) 1.98
Relation of lipoprotein subclasses as measured by proton nuclear magnetic resonance spectroscopy to coronary artery disease. Arterioscler Thromb Vasc Biol (1998) 1.95
Model for mammalian metallothionein structure. Proc Natl Acad Sci U S A (1983) 1.91
Reduction and binding of arsenate and dimethylarsinate by glutathione: a magnetic resonance study. Chem Biol Interact (1994) 1.77
Loci for CETP, LPL, LIPC, and APOC3 affect plasma lipoprotein size and sub-population distribution in Hispanic and non-Hispanic white subjects: the Columbia University BioMarkers Study. Nutr Metab Cardiovasc Dis (2002) 1.61
Structure of an invertebrate metallothionein from Scylla serrata. J Biol Chem (1982) 1.56
Evidence for site-selective metal binding in calf liver metallothionein. J Biol Chem (1982) 1.55
Location of polar substituents and fatty acyl chains on lipid A precursors from a 3-deoxy-D-manno-octulosonic acid-deficient mutant of Salmonella typhimurium. Studies by 1H, 13C, and 31P nuclear magnetic resonance. J Biol Chem (1985) 1.46
Structure and metal-binding properties of lipopolysaccharides from heptoseless mutants of Escherichia coli studied by 13C and 31P nuclear magnetic resonance. J Biol Chem (1983) 1.44
Molecular properties of acyl carrier protein derivatives. J Biol Chem (1981) 1.40
Characterization of lipopolysaccharide from a heptoseless mutant of Escherichia coli by carbon 13 nuclear magnetic resonance. J Biol Chem (1983) 1.37
Products of metal exchange reactions of metallothionein. Biochemistry (1985) 1.33
Association of the Sst-I polymorphism at the APOC3 gene locus with variations in lipid levels, lipoprotein subclass profiles and coronary heart disease risk: the Framingham offspring study. Atherosclerosis (2001) 1.27
Characterization and chemical properties of phosphoribosylamine, an unstable intermediate in the de novo purine biosynthetic pathway. Biochemistry (1988) 1.20
Transfer of arsenite from glutathione to dithiols: a model of interaction. Chem Res Toxicol (1994) 1.15
113Cd NMR study of a metallothionein fragment. Evidence for a two-domain structure. J Biol Chem (1982) 1.14
Levels and correlates of LDL and VLDL particle sizes among children: the Bogalusa heart study. Atherosclerosis (2000) 1.09
Association of the A-204C polymorphism in the cholesterol 7alpha-hydroxylase gene with variations in plasma low density lipoprotein cholesterol levels in the Framingham Offspring Study. J Lipid Res (1999) 1.08
Nuclear magnetic resonance spectroscopy. Carbon-13 spin-lattice relaxation time measurements of amino acids. Proc Natl Acad Sci U S A (1974) 1.07
Asparaginase-associated lipid abnormalities in children with acute lymphoblastic leukemia. Blood (1997) 1.05
NMR spectroscopic studies of I = 1/2 metal ions in biological systems. Biochem Cell Biol (1998) 1.04
Complexation of arsenic species in rabbit erythrocytes. Chem Res Toxicol (1995) 1.04
1H NMR studies on bovine cyclophilin: preliminary structural characterization of this specific cyclosporin A binding protein. Biochemistry (1986) 1.03
Association of the C-514T polymorphism in the hepatic lipase gene with variations in lipoprotein subclass profiles: The Framingham Offspring Study. Arterioscler Thromb Vasc Biol (2000) 1.03
Nitric oxide selectively releases metals from the amino-terminal domain of metallothioneins: potential role at inflammatory sites. FASEB J (2001) 1.03
Relative contributions of chemical exchange and other relaxation mechanisms in protein solutions and tissues. Magn Reson Med (1989) 1.00
Nuclear magnetic resonance-determined lipoprotein subclass profile in the DCCT/EDIC cohort: associations with carotid intima-media thickness. Diabet Med (2006) 0.98
Distribution and correlates of high-density lipoprotein subclasses among children and adolescents. Metabolism (2001) 0.97
Structure elucidation of the metal-binding sites in metallothionein by 113Cd NMR. Fed Proc (1982) 0.97
Hepatic lipase activity influences high density lipoprotein subclass distribution in normotriglyceridemic men. Genetic and pharmacological evidence. J Lipid Res (1999) 0.97
Three-dimensional solution structure of Callinectes sapidus metallothionein-1 determined by homonuclear and heteronuclear magnetic resonance spectroscopy. Biochemistry (1995) 0.95
31P nuclear magnetic resonance evidence for polyphosphoinositide associated with the hydrophobic segment of glycophorin A. Biochemistry (1977) 0.94
Mandibular metastasis in a patient with pulmonary adenocarcinoma. Dentomaxillofac Radiol (2006) 0.93
[13C]Valine metabolism in methylmalonicacidemia using nuclear magnetic resonance: propinonate as an obligate intermediate. Proc Natl Acad Sci U S A (1975) 0.92
Structural elements pertinent to the interaction of cyclosporin A with its specific receptor protein, cyclophilin. Biochem Pharmacol (1990) 0.91
Localization of the free radical on the flavin mononucleotide of the air-stable semiquinone state of NADPH-cytochrome P-450 reductase using 31P NMR spectroscopy. Biochemistry (1986) 0.91
Comparative Cd-113 nuclear magnetic resonance studies of Cd(II)-substituted blue copper proteins. J Biol Chem (1984) 0.90
1H NMR studies on bovine cyclophilin: preliminary structural characterization of its complex with cyclosporin A. Biochemistry (1990) 0.90
Biologically active Arg-Gly-Asp oligopeptides assume a type II beta-turn in solution. Biochemistry (1993) 0.90
HPLC characterization of Ag+ and Cu+ metal exchange reactions with Zn- and Cd-metallothioneins. Biochemistry (1996) 0.89
Nuclear magnetic resonance spectroscopy: reinvestigation of carbon-13 spin-lattice relaxation time measurements of amino acids. Proc Natl Acad Sci U S A (1975) 0.89
Acquired pulmonary arteriovenous malformation secondary to hydatid cyst operation. Thorac Cardiovasc Surg (2007) 0.89
113Cd nmr study of the metal cluster structure of human liver metallothionein. J Inorg Biochem (1982) 0.88
NMR spectroscopy of 113Cd(II)-substituted gene 32 protein. Biochemistry (1989) 0.88
Chemical and carbon-13 nuclear magnetic resonance studies of the blood group M and N active sialoglycopeptides from human glycophorin A. J Biol Chem (1981) 0.88
Association of the A/T54 polymorphism in the intestinal fatty acid binding protein with variations in plasma lipids in the Framingham Offspring Study. Atherosclerosis (2001) 0.87
31P NMR spectroscopic studies on purified, native and cloned, expressed forms of NADPH-cytochrome P450 reductase. Biochemistry (1992) 0.87
Tyrosyl-base-phenylalanyl intercalation in gene 5 protein-DNA complexes: proton nuclear magnetic resonance of selectively deuterated gene 5 protein. Biochemistry (1978) 0.87
Multi-center reproducibility of neurochemical profiles in the human brain at 7 T. NMR Biomed (2015) 0.87
19F nuclear magnetic resonance studies of lipid bilayer systems. I. J Am Chem Soc (1976) 0.86
Structure of gene 5 protein-oligodeoxynucleotide complexes as determined by 1H, 19F, and 31P nuclear magnetic resonance. Biochemistry (1976) 0.86
T102C polymorphism of the 5-HT2A receptor gene may be associated with temporomandibular dysfunction. Oral Dis (2004) 0.86
Letter: Cadmium-113 Fourier transform nuclear magnetic resonance of cadmium(II) carbonic anhydrases and cadmium(II) alkaline phosphatase. J Am Chem Soc (1976) 0.85
Studies of factors affecting the design of NMR contrast agents: manganese in blood as a model system. Magn Reson Med (1984) 0.85
Absence of association between genetic variation in the promoter of the microsomal triglyceride transfer protein gene and plasma lipoproteins in the Framingham Offspring Study. Atherosclerosis (2000) 0.85
Biphasic kinetics of Zn2+ removal from Zn metallothionein by nitrilotriacetate are associated with differential reactivity of the two metal clusters. J Inorg Biochem (1998) 0.84
31P NMR of phosphate and phosphonate complexes of metalloalkaline phosphatases. J Biol Chem (1976) 0.84
Characterization of the calcium-binding sites of calcineurin B. FEBS Lett (1995) 0.84
Carbon-13 nuclear magnetic resonance as a probe of side chain orientation and mobility in carboxymethylated human carbonic anhydrase B. Biochemistry (1978) 0.84
Effectiveness of high doses of simvastatin as monotherapy in mixed hyperlipidemia. Am J Cardiol (2001) 0.83
Whole-brain glutamate metabolism evaluated by steady-state kinetics using a double-isotope procedure: effects of gabapentin. J Neurochem (2004) 0.83
3D solution structure of copper and silver-substituted yeast metallothioneins. FEBS Lett (1996) 0.83
m-Fluorotyrosine substitution in beta-galactosidase; evidence for the existence of a catalytically active tyrosine. Biochem Biophys Res Commun (1985) 0.83
Influence of glycogen on water proton relaxation times. Magn Reson Med (1986) 0.83
Expression of human cyclophilin-40 and the effect of the His141-->Trp mutation on catalysis and cyclosporin A binding. Eur J Biochem (1995) 0.83
Completion pneumonectomy for bronchiectasis: morbidity, mortality and management. Thorac Cardiovasc Surg (2008) 0.83
111Cd NMR studies of the domain specificity of Ag+ and Cu+ binding to metallothionein. Biochemistry (1996) 0.83
NMR determination of the structures of peroxycobalt(III) bleomycin and cobalt(III) bleomycin, products of the aerobic oxidation of cobalt(II) bleomycin by dioxygen. Biochemistry (1994) 0.83
NMR analysis of the structure and metal sequestering properties of metallothioneins. Environ Health Perspect (1984) 0.82
Regulation of cerebral glucose metabolism. Minerva Endocrinol (2006) 0.82
Oxidative dimerization in metallothionein is a result of intermolecular disulphide bonds between cysteines in the alpha-domain. Biochem J (2001) 0.82
Characterization of the histidine residues in alkaline phosphatase by carbon-13 nuclear magnetic resonance. Biochemistry (1980) 0.82
Phosphorus-31 NMR studies of E. coli ribosomes. Nucleic Acids Res (1978) 0.81
An analysis of magnetic cross-relaxation between water and methylene protons in a model system. Magn Reson Med (1989) 0.81
Mutation of invariant cysteines of mammalian metallothionein alters metal binding capacity, cadmium resistance, and 113Cd NMR spectrum. J Biol Chem (1991) 0.81
Preparation and 113Cd NMR studies of homogeneous reconstituted metallothionein: reaffirmation of the two-cluster arrangement of metals. Biochemistry (1985) 0.81
Letter: Concerning the intermediacy of uro'gen III and of a heptacarboxylic uro'gen in corrinoid biosynthesis. J Am Chem Soc (1975) 0.81
Quantitative studies of hydrodynamic effects and cross-relaxation in protein solutions and tissues with proton and deuteron longitudinal relaxation times. Magn Reson Med (1990) 0.81
Copper- and silver-substituted yeast metallothioneins: sequential 1H NMR assignments reflecting conformational heterogeneity at the C terminus. Biochemistry (1993) 0.81
4-Fluorotryptophan alkaline phosphatase from E. coli: preparation, properties, and 19F NMR spectrum. Biochem Biophys Res Commun (1976) 0.81
Three-dimensional structure and dynamics of a brain specific growth inhibitory factor: metallothionein-3. Biochemistry (2001) 0.81
Characterization of the properties of the multiple metal binding sites in alkaline phosphatase by carbon-13 nuclear magnetic resonance. Biochemistry (1980) 0.80
Solution structure of cyclosporin A and a nonimmunosuppressive analog bound to fully deuterated cyclophilin. Biochemistry (1992) 0.80
HIV protease substrate conformation: modulation by cyclophilin A. FEBS Lett (1997) 0.80
Racial differences in low-density lipoprotein particle size in families at high risk for premature coronary heart disease. Ethn Dis (2001) 0.79
Apolipoprotein epsilon2 allele is associated with an anti-atherogenic lipoprotein profile in children: The Columbia University BioMarkers Study. Pediatrics (2000) 0.79
Cadmium-zinc interactions in the Ehrlich cell: metallothionein and other sites. Experientia Suppl (1987) 0.79
Allosteric interactions between metal ion and phosphate at the active sites of alkaline phosphatase as determined by 31P NMR and 113Cd NMR. J Biol Chem (1977) 0.79
Magnetic resonance, pathology and physiology of the BA1112 rhabdomyosarcoma in vivo. Invest Radiol (1988) 0.79